OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Redefining the Cut-Off Ranges for TSH Based on the Clinical Picture, Results of Neuroimaging and Laboratory Tests in Unsupervised Cluster Analysis as Individualized Diagnosis of Early Schizophrenia
Natalia Śmierciak, Marta Szwajca, T Popiela, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 2, pp. 247-247
Open Access | Times Cited: 18
Natalia Śmierciak, Marta Szwajca, T Popiela, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 2, pp. 247-247
Open Access | Times Cited: 18
Showing 18 citing articles:
The Association of the Oral Microbiota with the Effects of Acid Stress Induced by an Increase of Brain Lactate in Schizophrenia Patients
Wirginia Krzyściak, Paulina Karcz, Beata Bystrowska, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 240-240
Open Access | Times Cited: 8
Wirginia Krzyściak, Paulina Karcz, Beata Bystrowska, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 240-240
Open Access | Times Cited: 8
Benefits and Meaning of Lipids Profile in Relation to Oxidative Balance and Brain Morphology in Schizophrenia
Natalia Śmierciak, Wirginia Krzyściak, Marta Szwajca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11375-11375
Open Access | Times Cited: 5
Natalia Śmierciak, Wirginia Krzyściak, Marta Szwajca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11375-11375
Open Access | Times Cited: 5
Immunological routine laboratory parameters at admission influence the improvement of positive symptoms in schizophrenia patients after pharmacological treatment
Anna Skalniak, Wirginia Krzyściak, Natalia Śmierciak, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 4
Anna Skalniak, Wirginia Krzyściak, Natalia Śmierciak, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 4
From periphery immunity to central domain through clinical interview as a new insight on schizophrenia
Wirginia Krzyściak, Marta Szwajca, Natalia Śmierciak, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Wirginia Krzyściak, Marta Szwajca, Natalia Śmierciak, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Pathophysiological Electrolyte Changes Connoted via Antagonism of Serotonin Receptor in Experimental Animals
Mohammed Mahmood, Mohammed A Younes, Mohammed Saarti
Pharmacognosy Journal (2022) Vol. 14, Iss. 5, pp. 548-552
Open Access | Times Cited: 6
Mohammed Mahmood, Mohammed A Younes, Mohammed Saarti
Pharmacognosy Journal (2022) Vol. 14, Iss. 5, pp. 548-552
Open Access | Times Cited: 6
Association of Blood Metabolomics Biomarkers with Brain Metabolites and Patient-Reported Outcomes as a New Approach in Individualized Diagnosis of Schizophrenia
Wirginia Krzyściak, Beata Bystrowska, Paulina Karcz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2294-2294
Open Access
Wirginia Krzyściak, Beata Bystrowska, Paulina Karcz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2294-2294
Open Access
Inflammatory Thyroid Changes Following Serotonin Receptor Blocking in Experimental Rats
Muthear N Dawood, Karam A. Aldabbagh, Zahraa Alsarraf
Pharmacognosy Journal (2023) Vol. 15, Iss. 1, pp. 189-193
Open Access
Muthear N Dawood, Karam A. Aldabbagh, Zahraa Alsarraf
Pharmacognosy Journal (2023) Vol. 15, Iss. 1, pp. 189-193
Open Access
Adherence of patients with schizophrenia to hypothyroidism treatment
Shay Gur, Shira Weizman, Haggai Hermesh, et al.
Cambridge Prisms Global Mental Health (2023) Vol. 10
Open Access
Shay Gur, Shira Weizman, Haggai Hermesh, et al.
Cambridge Prisms Global Mental Health (2023) Vol. 10
Open Access
Decision: Adherence of patients with schizophrenia to hypothyroidism treatment — R1/PR9
Shay Gur, Shira Weizman, Haggai Hermesh, et al.
(2023)
Open Access
Shay Gur, Shira Weizman, Haggai Hermesh, et al.
(2023)
Open Access
Recommendation: Adherence of patients with schizophrenia to hypothyroidism treatment — R1/PR8
Shay Gur, Shira Weizman, Haggai Hermesh, et al.
(2023)
Open Access
Shay Gur, Shira Weizman, Haggai Hermesh, et al.
(2023)
Open Access
Review: Adherence of patients with schizophrenia to hypothyroidism treatment — R1/PR7
Shay Gur, Shira Weizman, Haggai Hermesh, et al.
(2023)
Open Access
Shay Gur, Shira Weizman, Haggai Hermesh, et al.
(2023)
Open Access
Author comment: Adherence of patients with schizophrenia to hypothyroidism treatment — R1/PR6
Shay Gur
(2023)
Open Access
Shay Gur
(2023)
Open Access
Decision: Adherence of patients with schizophrenia to hypothyroidism treatment — R0/PR5
Shay Gur, Shira Weizman, Haggai Hermesh, et al.
(2023)
Open Access
Shay Gur, Shira Weizman, Haggai Hermesh, et al.
(2023)
Open Access
Review: Adherence of patients with schizophrenia to hypothyroidism treatment — R0/PR3
Shay Gur, Shira Weizman, Haggai Hermesh, et al.
(2023)
Open Access
Shay Gur, Shira Weizman, Haggai Hermesh, et al.
(2023)
Open Access
Recommendation: Adherence of patients with schizophrenia to hypothyroidism treatment — R0/PR4
Shay Gur, Shira Weizman, Haggai Hermesh, et al.
(2023)
Open Access
Shay Gur, Shira Weizman, Haggai Hermesh, et al.
(2023)
Open Access
Review: Adherence of patients with schizophrenia to hypothyroidism treatment — R0/PR2
Shay Gur, Shira Weizman, Haggai Hermesh, et al.
(2023)
Open Access
Shay Gur, Shira Weizman, Haggai Hermesh, et al.
(2023)
Open Access
